Hepatitis B Virus | Appendix B: Panel Roster and Financial Disclosures | Adult and Adolescent Opportunistic Infection | ClinicalInfo

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Updated

Aug. 01, 2019

Reviewed

Aug. 01, 2019

Appendix B: Panel Roster and Financial Disclosures

Hepatitis B Virus

Hepatitis B Virus Infection
Member		Financial Disclosure
Member		Company	Relationship
Bhattacharya, Debika	University of California, Los Angeles	AbbVie	Research Support
Bhattacharya, Debika	University of California, Los Angeles	National Institutes of Health	Research Support
Harris, Aaron	Centers for Disease Control and Prevention	None	N/A
Hawkins, Claudia	Northwestern University	National Institutes of Health	Research Support
Peters, Marion	University of California, San Francisco	Abbott	Advisory Board
Peters, Marion	University of California, San Francisco	Antios	Advisory Board
Thio, Chole*	Johns Hopkins University	Sanofi U.S.	Research Support
* Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Documents

Section OnlyPDF (337.79 KB)

Full GuidelinePDF (3.78 MB)

Tables OnlyPDF (481.21 KB)

Download Guidelines

Section OnlyPDF (337.79 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)